Contineum Therapeutics Inc
For the period ended May 20, 2024. Filed May 20, 2024.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
May 20, 2024 · Filed May 20, 2024
Use the contents to explore the available documents and sections.
CTNM$9.52+8.1%Stored close · as of Nov 6, 2026
Contents
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of ** the Securities Exchange Act of 1934**
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.